X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA WOCKHARDT LTD. NATCO PHARMA/
WOCKHARDT LTD.
 
P/E (TTM) x 33.0 16.4 200.9% View Chart
P/BV x 16.8 1.7 1,002.9% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 NATCO PHARMA   WOCKHARDT LTD.
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
WOCKHARDT LTD.
Mar-16
NATCO PHARMA/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs8772,000 43.9%   
Low Rs424706 60.0%   
Sales per share (Unadj.) Rs223.4403.7 55.3%  
Earnings per share (Unadj.) Rs31.129.5 105.4%  
Cash flow per share (Unadj.) Rs40.342.4 95.1%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs219.5323.4 67.9%  
Shares outstanding (eoy) m33.07110.51 29.9%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.93.4 86.8%   
Avg P/E ratio x20.945.9 45.6%  
P/CF ratio (eoy) x16.131.9 50.6%  
Price / Book Value ratio x3.04.2 70.8%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m21,504149,509 14.4%   
No. of employees `000NA7.4 0.0%   
Total wages/salary Rs m1,1289,443 11.9%   
Avg. sales/employee Rs ThNM6,048.6-  
Avg. wages/employee Rs ThNM1,280.2-  
Avg. net profit/employee Rs ThNM441.5-  
INCOME DATA
Net Sales Rs m7,38944,614 16.6%  
Other income Rs m167970 17.2%   
Total revenues Rs m7,55645,584 16.6%   
Gross profit Rs m1,7935,038 35.6%  
Depreciation Rs m3041,426 21.4%   
Interest Rs m3661,012 36.2%   
Profit before tax Rs m1,2903,570 36.1%   
Minority Interest Rs m46-65 -71.1%   
Prior Period Items Rs m06 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m309255 121.2%   
Profit after tax Rs m1,0273,257 31.5%  
Gross profit margin %24.311.3 214.9%  
Effective tax rate %23.97.1 335.3%   
Net profit margin %13.97.3 190.5%  
BALANCE SHEET DATA
Current assets Rs m3,68139,906 9.2%   
Current liabilities Rs m3,12318,423 17.0%   
Net working cap to sales %7.648.2 15.7%  
Current ratio x1.22.2 54.4%  
Inventory Days Days8990 99.2%  
Debtors Days Days5998 59.8%  
Net fixed assets Rs m7,68535,832 21.4%   
Share capital Rs m331553 59.9%   
"Free" reserves Rs m6,67030,370 22.0%   
Net worth Rs m7,25935,739 20.3%   
Long term debt Rs m95516,542 5.8%   
Total assets Rs m11,95779,522 15.0%  
Interest coverage x4.54.5 99.9%   
Debt to equity ratio x0.10.5 28.4%  
Sales to assets ratio x0.60.6 110.1%   
Return on assets %11.75.4 217.1%  
Return on equity %14.29.1 155.3%  
Return on capital %20.78.7 239.5%  
Exports to sales %39.411.6 339.2%   
Imports to sales %5.74.5 127.8%   
Exports (fob) Rs m2,9085,177 56.2%   
Imports (cif) Rs m4211,990 21.2%   
Fx inflow Rs m3,4457,589 45.4%   
Fx outflow Rs m7032,878 24.4%   
Net fx Rs m2,7434,711 58.2%   
CASH FLOW
From Operations Rs m1,440716 201.1%  
From Investments Rs m-1,089-8,182 13.3%  
From Financial Activity Rs m-3532,543 -13.9%  
Net Cashflow Rs m-1-4,923 0.0%  

Share Holding

Indian Promoters % 52.0 74.5 69.9%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 2.3 340.9%  
FIIs % 16.6 7.7 216.0%  
ADR/GDR % 0.0 0.1 -  
Free float % 26.0 15.4 168.8%  
Shareholders   25,395 67,757 37.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   PANACEA BIOTECH  DISHMAN PHARMA  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare NATCO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 22, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - ABBOTT INDIA COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS